Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance
Figure 1
Fasting serum IGF-I before and during pioglitazone treatment in type 2 diabetes (T2D) and impaired glucose tolerance (IGT). †Mann-Whitney -test, . *Wilcoxon matched pairs test, .